Charles River Laboratories | CRL - Market Capitalization

Stock Price
201.30
Daily Change
-0.11 -0.05%
Monthly
-3.37%
Yearly
21.36%
Q1 Forecast
204.00

Charles River Laboratories reported $10.24B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 41.49B 8.93B Sep/2025
Align Technology USD 11.92B 2.84B Feb/2026
Bio-Rad Laboratories USD 7.61B 1.08B Sep/2025
Bruker USD 4.93B 1.31B Sep/2025
Cardinal Health USD 37.29B 2.81B Sep/2025
Charles River Laboratories USD 7.31B 57M Sep/2025
Cigna USD 76.94B 11.29B Sep/2025
CVS Health USD 95.62B 8.22B Sep/2025
Danaher USD 161.7B 29.34B Dec/2025
Dentsply International USD 2.53B 633M Sep/2025
Elevance Health USD 77.91B 5.15B Dec/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Hologic USD 16.62B 1.67B Dec/2025
Humana USD 31.29B 1.78B Sep/2025
Illumina USD 14.09B 1.01B Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
IQVIA Holdings USD 32.29B 5.03B Sep/2025
Laboratory Of America USD 23.83B 1.85B Sep/2025
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 109.13B 13.04B Feb/2026
Merck EUR 47.59B 239.13M Sep/2025
Mettler Toledo International USD 25.29B 878M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Quest Diagnostics USD 21.31B 1.26B Sep/2025
Revvity USD 13.23B 3.47B Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
United Therapeutics USD 18.96B 6B Sep/2025
UnitedHealth USD 265.18B 33.84B Feb/2026
Waters USD 17.36B 3.61B Sep/2025
West Pharmaceutical Services USD 18.86B 3.14B Sep/2025